WHO ICTRP trial
Elucidation of the effect of Lacticaseibacillus paracasei Shirota strain (LcS)…
JPRN-jRCTs021220028 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs021220028 |
|---|---|
| Public title | Elucidation of the effect of Lacticaseibacillus paracasei Shirota strain (LcS) in human intestine |
| Scientific title | Elucidation of the effect of Lacticaseibacillus paracasei Shirota strain (LcS) in human intestine |
| Primary sponsor | Chinda Daisuke |
| Secondary sponsors | Fukuda Shinsaku |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | N/A N/A |
| Interventions | Oral Yakult 1000 given on daily for 30 days from 44 to 71 days after the start of the test. |
| Registration date | Nov 17, 2022 |
| Target size | 10 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: